MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/alz.13370

Медицинская библиотека · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

The Early-Onset Alzheimer's Disease Whole-Genome Sequencing Project: Study design and methodology.

Ray Nicholas R, Ayodele Temitope, Jean-Francois Melissa, Baez Penelope, Fernandez Victoria, Bradley Joseph, Crane Paul K, Dalgard Clifton L, Kuzma Amanda, Nicaretta Heather, Sims Rebecca, Williams Julie, Cuccaro Michael L, Pericak-Vance Margaret A, Mayeux Richard, Wang Li-San, Schellenberg Gerard D, Cruchaga Carlos, Beecham Gary W, Reitz Christiane

СтатьяПоддержка исследования: вне правительства СШАПоддержка NIH: внешняя программаПеревод пока не подготовлен

Аннотация

INTRODUCTION

Sequencing efforts to identify genetic variants and pathways underlying Alzheimer's disease (AD) have largely focused on late-onset AD although early-onset AD (EOAD), accounting for ∼10% of cases, is largely unexplained by known mutations, resulting in a lack of understanding of its molecular etiology.

METHODS

Whole-genome sequencing and harmonization of clinical, neuropathological, and biomarker data of over 5000 EOAD cases of diverse ancestries.

RESULTS

A publicly available genomics resource for EOAD with extensive harmonized phenotypes. Primary analysis will (1) identify novel EOAD risk loci and druggable targets; (2) assess local-ancestry effects; (3) create EOAD prediction models; and (4) assess genetic overlap with cardiovascular and other traits.

DISCUSSION: This novel resource complements over 50,000 control and late-onset AD samples generated through the Alzheimer's Disease Sequencing Project (ADSP). The harmonized EOAD/ADSP joint call will be available through upcoming ADSP data releases and will allow for additional analyses across the full onset range.

HIGHLIGHTS: Sequencing efforts to identify genetic variants and pathways underlying Alzheimer's disease (AD) have largely focused on late-onset AD although early-onset AD (EOAD), accounting for ∼10% of cases, is largely unexplained by known mutations. This results in a significant lack of understanding of the molecular etiology of this devastating form of the disease. The Early-Onset Alzheimer's Disease Whole-genome Sequencing Project is a collaborative initiative to generate a large-scale genomics resource for early-onset Alzheimer's disease with extensive harmonized phenotype data. Primary analyses are designed to (1) identify novel EOAD risk and protective loci and druggable targets; (2) assess local-ancestry effects; (3) create EOAD prediction models; and (4) assess genetic overlap with cardiovascular and other traits. The harmonized genomic and phenotypic data from this initiative will be available through NIAGADS.

Для цитирования: Ray Nicholas R, Ayodele Temitope, Jean-Francois Melissa, Baez Penelope, Fernandez Victoria, Bradley Joseph, Crane Paul K, Dalgard Clifton L, Kuzma Amanda, Nicaretta Heather, Sims Rebecca, Williams Julie, Cuccaro Michael L, Pericak-Vance Margaret A, Mayeux Richard, Wang Li-San, Schellenberg Gerard D, Cruchaga Carlos, Beecham Gary W, Reitz Christiane. The Early-Onset Alzheimer's Disease Whole-Genome Sequencing Project: Study design and methodology.. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2023. DOI: 10.1002/alz.13370.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.